| Actionable mutations in pancreatic cancer : where targeted therapies are making a difference | BMJ open gastroenterology |  | | 2025 | 7 | 111 |
|
| Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review | Clinical colorectal cancer | | | 2025 | 19 | 321 |
|
| Narrative Review : Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer Patients | Cancers | | | 2025 | 38 | 198 |
|
| Prise en charge du cancer du rectum localisé en 2024 | Revue médicale suisse | | | 2024 | 151 | 2 |
|
| Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy | Cells | | | 2023 | 122 | 247 |
|
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | | | 2022 | 261 | 270 |
|
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | | | 2022 | 189 | 206 |
|
| Emerging Trends for Radio-Immunotherapy in Rectal Cancer | Cancers | | | 2021 | 60 | 195 |
|
| Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer | Cancers | | | 2021 | 107 | 1,559 |
|
